REG - Zotefoams PLC - Result of the 2022 Annual General Meeting

ZotefoamsAnnouncement

25/05/2022 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220525:nRSY7986Ma&default-theme=true

RNS Number : 7986M  Zotefoams PLC  25 May 2022

Zotefoams plc

('the Company')

 

Result of the 2022 Annual General Meeting

 

25 May 2022 - The Company announces that at its Annual General Meeting held on
25 May 2022 at its offices at 675 Mitcham Road, Croydon CR9 3AL, all of the
resolutions tabled at the meeting were passed on a poll vote. Resolutions 1 to
13 inclusive were passed as ordinary resolutions and resolutions 14 to 17
inclusive were passed as special resolutions.

 

The total number of ordinary shares in issue in relation to the AGM is
48,621,234. Votes were cast by shareholders in respect of 30,901,851 ordinary
shares amounting to 63.5% of the issued share capital.

 

The votes cast* were recorded as follows:

 

 Resolution                                                                               For         % of votes cast  Against    % of votes cast  Votes Withheld
 1.      To receive the Annual Report of the Company for the year ended 31 December       30,901,851  100              0          0                123
         2021
 2.      To approve the Annual Statement by the Chair of the Remuneration Committee and   30,766,637  99.6             123,706    0.40             11,631
         the Annual Report on Remuneration for the year ended 31 December 2021 set out
         on pages 88 to 99 of the Annual Report.
 3.      To declare a final dividend for the year ended 31 December 2021 of 4.40 pence    30,901,851  100              0          0                123
         per ordinary share, such dividend to be payable on 1 June 2022 to shareholders
         on the register of members of the Company at the close of business on 6 May
         2022.
 4.      To re-elect S P Good as a Director.                                              28,713,535  92.92            2,187,376  7.08             1,063
 5.      To re-elect D B Stirling as a Director.                                          30,891,727  99.97            9,184      0.03             1,063
 6.      To re-elect G C McGrath as a Director.                                           30,891,594  99.97            9,317      0.03             1,063
 7.      To re-elect J D Carling as a Director.                                           30,768,067  99.57            132,844    0.43             1,063
 8.      To re-elect A M Fielding as a Director.                                          30,657,251  99.60            123,660    0.40             121,063
 9.      To re-elect D G Robertson as a Director.                                         30,768,067  99.57            132,844    0.43             1,063
 10.     To re-elect C A Wall as a Director.                                              30,777,251  99.60            123,660    0.40             1,063
 11.     To re-appoint PKF Littlejohn LLP as Auditor of the Company.                      30,760,355  99.93            20,556     0.07             121,063
 12.     To authorise the Audit Committee to determine the Auditor's remuneration.        30,868,035  99.93            20,556     0.07             13,383
 13.     To authorise the Directors to allot shares.                                      30,752,773  99.55            138,954    0.45             10,247
 14.     To authorise the Directors to allot equity securities for cash.                  30,771,577  99.61            120,150    0.39             10,247
 15.     To authorise the Directors, in addition to resolution 14, to allot further       30,768,441  99.61            120,150    0.39             13,383
         equity securities for financing (and refinancing) purposes only.
 16.     To authorise market purchases of shares.                                         30,891,468  100              1,199      0                9,307
 17.     That a general meeting other than an annual general meeting may be called on     30,118,029  97.50            773,698    2.50             10,247
         not less than 14 clear days' notice.

 

*  Total votes cast excludes votes withheld as a vote withheld is not a vote
in law.

 

Further details of the resolutions (including the text of the resolutions) are
given in the Notice of the 2022 Annual General Meeting, which is on page 156
of the 2021 Annual Report and which is also available on the Company's
website.

 

Pursuant to Listing Rule 9.6, the Company also confirms that a copy of all
relevant resolutions passed at its AGM will shortly be made available for
public inspection via the National Storage Mechanism.

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets
worldwide. Zotefoams uses its own cellular materials to manufacture
T-FIT(®) advanced insulation for demanding industrial
markets. Zotefoams also owns and licenses patented microcellular foam
technology to reduce plastic use in extrusion applications and for ReZorce(®)
mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing
sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma,
USA (foam products manufacture and conversion), Massachusetts, USA (MuCell
Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com/)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks
of Zotefoams plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGFLFIFEIIEFIF